WHO ICTRP trial

Comparing Two Doses of Nebulized Dexmedetomidine to Control Blood Pressure and…

CTRI/2025/07/091864 · Clinical Trials Registry India (CTRI) · Recruiting

Key facts

Trial ID CTRI/2025/07/091864
Public title Comparing Two Doses of Nebulized Dexmedetomidine to Control Blood Pressure and Heart Rate During Intubation
Scientific title A comparative study of two different doses of nebulized dexmedetomidine for attenuation of hemodynamic responses to laryngoscopy and intubation. - NIL
Primary sponsor SRMS IMS
Registry Clinical Trials Registry India (CTRI)
Recruitment status Recruiting
Study type Interventional
Countries India
Interventions Intervention1: Nil: Nil Intervention2: Inhaled Dexmedetomidine (1 mcg/kg): 32 subjects will be administered. Dexmedetomidine nebulization at 1 mcg dose diluted in saline to make a total of 5 ml Group B: 32 subjects will be Control…
Registration date Jul 28, 2025
Target size 64
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations